BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8105297)

  • 1. Polymerase chain reaction and assessment of leprosy chemotherapy.
    Mistry NF; Antia NH
    Lancet; 1993 Oct; 342(8878):1060. PubMed ID: 8105297
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy.
    Jamil S; Keer JT; Lucas SB; Dockrell HM; Chiang TJ; Hussain R; Stoker NG
    Lancet; 1993 Jul; 342(8866):264-8. PubMed ID: 8101301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of LSR/A15 gene for Mycobacterium leprae detection in leprosy tissues using the polymerase chain reaction.
    Misra N; Ramesh V; Misra RS; Narayan NP; Colston MJ; Nath I
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):35-41. PubMed ID: 7730717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

  • 7. Modern sensitive techniques for the detection of Mycobacterium leprae.
    Ayliffe PR
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):451-64. PubMed ID: 1474284
    [No Abstract]   [Full Text] [Related]  

  • 8. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
    Mori S; Yotsu RR; Suzuki K; Makino M; Ishii N
    J Dermatol Sci; 2012 Sep; 67(3):192-4. PubMed ID: 22739027
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.
    Chae GT; Kim MJ; Kang TJ; Lee SB; Shin HK; Kim JP; Ko YH; Kim SH; Kim NH
    J Med Microbiol; 2002 May; 51(5):417-422. PubMed ID: 11990494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
    Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy is (still) here, but recognition is often delayed.
    Scollard DM
    South Med J; 2008 Jun; 101(6):583. PubMed ID: 18475232
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases.
    Lini N; Shankernarayan NP; Dharmalingam K
    J Med Microbiol; 2009 Jun; 58(Pt 6):753-759. PubMed ID: 19429751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.
    Ramasoota P; Wongwit W; Sampunachot P; Unnarat K; Ngamying M; Svenson SB
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):493-7. PubMed ID: 11289008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to define leprosy elimination as zero leprosy transmission?
    Smith CS; Aerts A; Kita E; Virmond M
    Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring the effects of preventive therapy in the Federated States of Micronesia.
    Cho SN; Walsh GP; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S19-22. PubMed ID: 10700932
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR.
    Kim SK; Lee SB; Kang TJ; Chae GT
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):27-32. PubMed ID: 12727362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
    Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
    Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium leprae genome sequence; a landmark achievement.
    Colston MJ
    Lepr Rev; 2001 Dec; 72(4):385-6. PubMed ID: 11826474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.